OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Healthcare professionals (HCPs) are not only worried about how they will get through COVID-19, they’re also concerned about the long-term well-being of their patients, according to a new survey published today by Fingerpaint.
The Fingerpaint COVID-19 HCP Survey showed that 59% percent of HCPs were worried about their patients not being diagnosed in a timely manner, and 58% believe their patients will not be able to obtain previously prescribed in-office/outpatient care. More than half of those surveyed (53%) don’t think their patients have the ability to utilize telemedicine and will not be able to refill their medications.
They believe the pandemic will have a long-term impact on their practice. In fact, 59% of them believe they won’t feel more hopeful about the current COVID-19 situation for at least 2 to 6 months.
“As brands refine their marketing efforts, it is important to have a deep understanding of what’s keeping HCPs awake at night and how this pandemic is impacting them and their patients,” said Michelle Petroff, head of Fingerpaint’s Conshohocken, PA, office. “Many of the HCPs reached in this survey are not just worried about the short-term issues, but are looking for long-term solutions.”
There was positive news in the survey. While overall 66% of HCPs reported feeling anxious about COVID-19 as it applies to their practice, only 5% went as far as saying that they feel defeated.
The survey link was sent in an email to about 16,000 contacts. Respondents were screened to ensure their status as healthcare professionals who reside in the United States, were board-certified in their specialty, and had a minimum of 4 and maximum of 40 years’ practice experience. A total of 116 healthcare professionals completed the online survey during the week of March, 2020.